<unk>  aims to induce immune tolerance where there is pathological or undesirable activation of the normal immune response. This can occur, for example, when an allogeneic transplantation patient develops an immune reaction to donor antigens, or when the body responds inappropriately to self antigens implicated in autoimmune diseases. It must provide absence of specific antibodies for exactly that antigenes. Research using animal models in transplantation and autoimmune diseases has led to early-phase human trials of<unk>  for autoimmune conditions like Type 1 Diabetes.
Tolerogenic therapy
Counterfeit medications
Antibiotic misuse
Preconditioning 
Fixed drug reaction
Overmedication
Spillover infection
Therapeutic inertia